Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 2
1948 2
1949 3
1950 2
1951 4
1952 3
1953 7
1954 9
1955 5
1956 10
1957 8
1958 11
1959 5
1960 9
1961 9
1962 8
1963 18
1964 15
1965 16
1966 5
1967 16
1968 16
1969 13
1970 14
1971 24
1972 10
1973 20
1974 10
1975 19
1976 12
1977 12
1978 17
1979 26
1980 20
1981 14
1982 21
1983 26
1984 22
1985 26
1986 22
1987 44
1988 29
1989 44
1990 38
1991 28
1992 45
1993 42
1994 46
1995 59
1996 45
1997 61
1998 63
1999 63
2000 73
2001 74
2002 57
2003 70
2004 78
2005 87
2006 97
2007 100
2008 123
2009 127
2010 132
2011 156
2012 190
2013 186
2014 178
2015 208
2016 228
2017 201
2018 231
2019 258
2020 266
2021 317
2022 350
2023 277
2024 276
2025 315
2026 74

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,322 results

Results by year

Filters applied: . Clear all
Page 1
Adrenocortical carcinoma: a practical guide for clinicians.
Fassnacht M, Puglisi S, Kimpel O, Terzolo M. Fassnacht M, et al. Lancet Diabetes Endocrinol. 2025 May;13(5):438-452. doi: 10.1016/S2213-8587(24)00378-4. Epub 2025 Mar 11. Lancet Diabetes Endocrinol. 2025. PMID: 40086465 Free article. Review.
Adrenocortical carcinoma is a rare endocrine malignancy. The management of patients with adrenocortical carcinoma is challenging for several reasons, including its heterogeneous but frequently aggressive biological behaviour; tumour-related hormonal ex …
Adrenocortical carcinoma is a rare endocrine malignancy. The management of patients with adrenocortical carcinoma …
Adrenocortical carcinoma.
Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD. Else T, et al. Endocr Rev. 2014 Apr;35(2):282-326. doi: 10.1210/er.2013-1029. Epub 2013 Dec 20. Endocr Rev. 2014. PMID: 24423978 Free PMC article. Review.
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy, often with an unfavorable prognosis. ...
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy, often with an unfavorable prognosis. ...
Pediatric adrenocortical carcinoma.
Ilanchezhian M, Varghese DG, Glod JW, Reilly KM, Widemann BC, Pommier Y, Kaplan RN, Del Rivero J. Ilanchezhian M, et al. Front Endocrinol (Lausanne). 2022 Oct 31;13:961650. doi: 10.3389/fendo.2022.961650. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36387865 Free PMC article. Review.
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy of the adrenal gland with an unfavorable prognosis. ...
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy of the adrenal gland with an unfavorable prognosis. ...
Adrenocortical carcinoma.
Baudin E; Endocrine Tumor Board of Gustave Roussy. Baudin E, et al. Endocrinol Metab Clin North Am. 2015 Jun;44(2):411-34. doi: 10.1016/j.ecl.2015.03.001. Endocrinol Metab Clin North Am. 2015. PMID: 26038209 Review.
Recent developments in the treatment of adrenocortical carcinoma (ACC) include diagnostic and prognostic risk stratification algorithms, increasing evidence of the impact of historical therapies on overall survival, and emerging targets from integrated epigenomic an …
Recent developments in the treatment of adrenocortical carcinoma (ACC) include diagnostic and prognostic risk stratification a …
Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease.
Libé R, Huillard O. Libé R, et al. Cancer Treat Res Commun. 2023;37:100759. doi: 10.1016/j.ctarc.2023.100759. Epub 2023 Sep 8. Cancer Treat Res Commun. 2023. PMID: 37690343 Free article. Review.
Adrenocortical carcinoma (ACC) is a rare cancer with an estimated incidence of 0.7 to 2.0 cases per 1 million population per year in the United States. ...
Adrenocortical carcinoma (ACC) is a rare cancer with an estimated incidence of 0.7 to 2.0 cases per 1 million population per y …
Adrenocortical carcinoma.
van Ditzhuijsen CI, van de Weijer R, Haak HR. van Ditzhuijsen CI, et al. Neth J Med. 2007 Feb;65(2):55-60. Neth J Med. 2007. PMID: 17379929 Free article. Review.
Adrenocortical carcinoma is a rare disease with a poor prognosis. Patients can present with a hormonal syndrome or with general symptoms from an abdominal mass. ...Using one of the international classification methods, histopathological research can in almost all ca …
Adrenocortical carcinoma is a rare disease with a poor prognosis. Patients can present with a hormonal syndrome or with genera …
Adrenocortical carcinoma.
Hasebe M, Shibue K, Honjo S, Hamasaki A. Hasebe M, et al. QJM. 2022 Jan 21;115(1):43-44. doi: 10.1093/qjmed/hcab276. QJM. 2022. PMID: 34726762 No abstract available.
Adrenocortical Carcinoma with Hypercortisolism.
Puglisi S, Perotti P, Pia A, Reimondo G, Terzolo M. Puglisi S, et al. Endocrinol Metab Clin North Am. 2018 Jun;47(2):395-407. doi: 10.1016/j.ecl.2018.02.003. Epub 2018 Apr 9. Endocrinol Metab Clin North Am. 2018. PMID: 29754640 Review.
Adrenocortical carcinoma (ACC) is a rare and aggressive tumor. ACC may be associated with different syndromes of hormone excess, most frequently Cushing's syndrome with or without hypersecretion of androgens. ...
Adrenocortical carcinoma (ACC) is a rare and aggressive tumor. ACC may be associated with different syndromes of hormone exces …
Adrenocortical carcinoma.
Roman S. Roman S. Curr Opin Oncol. 2006 Jan;18(1):36-42. doi: 10.1097/01.cco.0000198976.43992.14. Curr Opin Oncol. 2006. PMID: 16357562 Review.
PURPOSE OF REVIEW: Adrenocortical carcinoma is a rare malignancy, accounting for 0.02% of all annual cancers reported. ...No significant advances in the treatment of adrenocortical carcinoma have been developed. Surgery remains the mainstay for primary …
PURPOSE OF REVIEW: Adrenocortical carcinoma is a rare malignancy, accounting for 0.02% of all annual cancers reported. ...No s …
Update on Adrenocortical Carcinoma.
Sarrafan-Chaharsoughi Z, Yazdian Anari P, Malayeri AA, Naraev B, Del Rivero J. Sarrafan-Chaharsoughi Z, et al. Urol Clin North Am. 2025 May;52(2):275-286. doi: 10.1016/j.ucl.2025.01.009. Epub 2025 Mar 13. Urol Clin North Am. 2025. PMID: 40250894 Review.
Adrenocortical carcinoma (ACC) is an uncommon and highly aggressive form of cancer that originates from the adrenal glands. ...
Adrenocortical carcinoma (ACC) is an uncommon and highly aggressive form of cancer that originates from the adrenal glands. .. …
5,322 results